Serono exploring sale

Serono's stock jumped yesterday as word spread that Europe's largest biotech hired the Goldman Sachs Group to consult on "various strategic alternatives." This move indicates that Serono might be interested in putting itself up for sale, though the company maintains that it is not looking to jump into a deal just yet. The Bertarelli family currently owns 62% of the $10.8 billion firm.

- read this article from Dow Jones for more